Concepedia

Suzanne M. Fields

SM

11

Publications

666

Citations

11

H-Index

1989

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Joint Base San Antonio

Brooke Army Medical Center

University of North Carolina at Chapel Hill

International Drug Development

Suzanne M. Fields is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1989–1996

11

Publications

11

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.

David Rinaldi, Howard A. Burris, F. Andrew Dorr et al. · Journal of Clinical Oncology · 1995 · 152 citations

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.

Howard A. Burris, Rebecca Irvin, John G. Kuhn et al. · Journal of Clinical Oncology · 1993 · 135 citations

Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population.

Celeste Lindley, Stephen A. Bernard, Suzanne M. Fields · Journal of Clinical Oncology · 1989 · 96 citations

, , +12

Topoisomerase I Inhibitors: An Overview of the Camptothecin Analogs

Howard A. Burris, Suzanne M. Fields · Hematology/Oncology Clinics of North America · 1994 · 58 citations

, , +6

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)

T Rourke, Geoffrey R. Weiss, Pamela New et al. · Anti-Cancer Drugs · 1994 · 50 citations

Rows per page

1–5 of 11